Cargando…
Prostate cancer screening: what can we learn from randomised trials?
In this article, the principle of randomised trials are first described and then prostate cancer screening trials published to date are evaluated based on these principles. A summary of the randomised prostate cancer screening is provided. The conclusion that can be made from the results of the scre...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861281/ https://www.ncbi.nlm.nih.gov/pubmed/29594015 http://dx.doi.org/10.21037/tau.2017.12.13 |
_version_ | 1783308064006340608 |
---|---|
author | Auvinen, Anssi |
author_facet | Auvinen, Anssi |
author_sort | Auvinen, Anssi |
collection | PubMed |
description | In this article, the principle of randomised trials are first described and then prostate cancer screening trials published to date are evaluated based on these principles. A summary of the randomised prostate cancer screening is provided. The conclusion that can be made from the results of the screening trials, as well as limitations of the evidence and open questions are outlined in the end. |
format | Online Article Text |
id | pubmed-5861281 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-58612812018-03-28 Prostate cancer screening: what can we learn from randomised trials? Auvinen, Anssi Transl Androl Urol Review Article In this article, the principle of randomised trials are first described and then prostate cancer screening trials published to date are evaluated based on these principles. A summary of the randomised prostate cancer screening is provided. The conclusion that can be made from the results of the screening trials, as well as limitations of the evidence and open questions are outlined in the end. AME Publishing Company 2018-02 /pmc/articles/PMC5861281/ /pubmed/29594015 http://dx.doi.org/10.21037/tau.2017.12.13 Text en 2018 Translational Andrology and Urology. All rights reserved. |
spellingShingle | Review Article Auvinen, Anssi Prostate cancer screening: what can we learn from randomised trials? |
title | Prostate cancer screening: what can we learn from randomised trials? |
title_full | Prostate cancer screening: what can we learn from randomised trials? |
title_fullStr | Prostate cancer screening: what can we learn from randomised trials? |
title_full_unstemmed | Prostate cancer screening: what can we learn from randomised trials? |
title_short | Prostate cancer screening: what can we learn from randomised trials? |
title_sort | prostate cancer screening: what can we learn from randomised trials? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861281/ https://www.ncbi.nlm.nih.gov/pubmed/29594015 http://dx.doi.org/10.21037/tau.2017.12.13 |
work_keys_str_mv | AT auvinenanssi prostatecancerscreeningwhatcanwelearnfromrandomisedtrials |